CompletedNot Applicable

Preoperative Methylprednisolone in Endovascular Aortic Repair

Denmark150 participantsStarted 2009-10

Plain-language summary

The purpose of this study is to attenuate the systemic inflammatory response after Endovascular repair of abdominal aortic aneurysms, by administration of a single preoperative dosage of Methylprednisolone.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Elective endovascular repair of an asymptomatic abdominal aortic aneurysm. * Informed signed consent Exclusion Criteria: * Positive HIV status, positive hepatitis B or C status * Immunoinflammatory disease - except topically treated skin disease and respiratory disease. * Glaucoma * Gastric or duodenal ulcer * Systemic fungal infection * Immunosuppressive treatment * Current treatment for cancer * Allergy towards contents of Solu-Medrol * Alcohol consumption: Men \> 21 drinks and women \> 14 drinks weekly * Pregnancy * Lack of informed signed consent * Patients where follow up is planned at other location than Rigshospitalet.

What they're measuring

Systemic inflammatory response syndrome - SIRS

Timeframe: Within 5 postoperative days

Trial details

NCT IDNCT00989729

SponsorLouise de la Motte

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2013-01

View on ClinicalTrials.gov More Abdominal Aortic Aneurysms trials